Please provide your email address to receive an email when new articles are posted on . The FDA recently approved Adzenys XR-ODT for the treatment of attention ...
A recently filed patent (Publication Number: US20230263735A1) describes a film-coated tablet with specific compositions and properties. The tablet consists of a core tablet coated with two film layers ...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today ...
Please provide your email address to receive an email when new articles are posted on . APT-1011, a novel fluticasone orally disintegrating tablet, effectively induced histologic response, improved ...
Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...
RALEIGH, NC, September 8, 2009 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV TM ODT ...
Dr. Ofer Agid, Medical Head of Ambulatory Services in the Schizophrenia Division at the Centre for Addiction and Mental Health (CAMH) in Toronto, commented, "The introduction of Gen-Clozapine is ...
MALVERN, Pa., Nov. 18, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary ...
Rizatriptan (as benzoate) 10mg; orally-disintegrating tabs; peppermint flavor; contains phenylalanine. Maxalt-MLT Orally Disintegrating Tablets, 10 mg, are white to off-white, round lyophilized orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results